Diagnostic Tool Development Suppliers In North America

Our journey began in 2010, when the earliest team members began to explore the idea of a diagnostic test that could be used by anyone, anywhere. Click Diagnostics explores a number of markets and identifies sexual health as the direction to pursue. ...

We've manufactured over 8 million devices, three billion sensors, and developed the first FDA-cleared blood glucose meter/app for iPhone®. We've been featured by the New York Times and Fast Company, and work with some of the world's largest ...

Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...

Founded in 2009, Flagship Biosciences, Inc., is a technology-driven spatial biology and biomarker services company delivering the most accurate and informative data available. We are revolutionizing biomarker analysis to improve drug development and ...

We are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as a liquid biopsy. ...

FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...

Lumos Diagnostics specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test solutions to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and ...

Konan Medical develops and distributes innovative ophthalmic diagnostic devices that help clinicians diagnose and manage vision- threatening or potentially life-threatening disorders. Konan Medical USA is an ISO 13485, FDA Registered, MDSAP ...

MaxCyte. SeQure Dx, Inc. is applying state of the art genomics technologies for gene editor target profiling to advance discovery, clinical development, and diagnostic solutions. Our core technologies, GUIDE-seq and ONE-seq, enable identification of ...

CUSABIO is a National High-Tech Enterprise with research, production and sales in one. After 16 years of effort, CUSABIO has become a good partner to researchers through worldwide. We are dedicated to providing 60,000+ validated antibodies, 10,000+ ...

Through a lot of hard work, a license from the Wisconsin Alumni Research Foundation (WARF) and a desire to have an impact on human health, NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ...

The Genovis Group consists of Genovis AB, Sweden, and the wholly owned subsidiary Genovis Inc., USA. The company's shares are listed on Nasdaq First North Growth Market. Genovis’ business concept is to offer customers in the biopharmaceutical and ...

Labex Canada Inc. was established as a federally registered company in 2011 in Halifax, Nova Scotia, Canada. In 2015 a new facility was opened in Newmarket, Ontario, Canada. Since the beginning the company has been active in import/export/marketing ...

SA Scientific, Ltd. has proudly served clinical laboratories worldwide since 1984. We design, develop and manufacture a wide range of One-Step rapid tests for fertility and infectious diseases. SA Scientific has a tradition of producing excellent ...

Inspired by the ingenuity and passion of David Muir, Passy Muir is committed to enhancing quality of life through quality products, and a commitment to excellence in education. Diagnosed with muscular dystrophy, David Muir eventually became ...

Sepset Biosciences is a diagnostic company in advanced development of a blood test (Sepset-ER) for hospitals to identify patients in the emergency room (ER) who will acquire severe sepsis and have high risk for organ failure. Sepset’s test will ...

Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Established in 1987, the company began research activity for ...